Which metabolic screenings and medications can help manage midlife weight gain and insulin resistance?

Midlife weight gain and insulin resistance are incredibly common, especially during perimenopause and menopause. At Alloy, we focus on both metabolic screening and evidence based treatments to help you manage what is really happening beneath the surface.

âś… Metabolic Screenings to Consider

If you are noticing stubborn belly weight or difficulty losing weight despite healthy habits, these screenings can help clarify what is going on:

1. Blood Sugar Testing

  • Fasting blood glucose

  • Hemoglobin A1c, shows your average blood sugar over 3 months

  • Glucose tolerance test, evaluates how your body handles a sugar load Dr. Richa Mittal explains these tests in detail here: Spooked by Menopausal Weight Gain?

2. Insulin Testing

  • Fasting insulin levels

  • HOMA IR, insulin resistance index, calculated from glucose and insulin levelsThis is sometimes debated but can help identify early insulin resistance.

3. Body Composition and Metabolic Screening

BMI alone is not enough in midlife. More comprehensive evaluation may include:

  • Visceral fat measurement

  • Muscle mass assessment

  • Screening for prediabetes Dr. Mary Claire Haver discusses metabolic screening and identifying GLP 1 candidates here: Personalizing Menopause Treatment


đź’Š Medications That Can Help

1. GLP 1 Medications

These are some of the most effective tools we have for midlife weight gain and insulin resistance.

Options available through Alloy’s Weight Care program include:

  • Semaglutide, Wegovy®

  • Tirzepatide, Zepbound®

  • Compounded liraglutide

GLP 1s:

  • Reduce hunger and cravings

  • Improve insulin response

  • Lower blood sugar

  • Promote fat loss, including visceral belly fat

On average, patients lose about 15 percent of body weight over time when combined with lifestyle changes.

Learn more about how they work here: How GLP-1s Support Weight Loss & Metabolic Health Explore our program: Alloy Weight Care Program

2. Menopausal Hormone Therapy, MHT

MHT does not directly cause weight loss, but it:

  • Improves fat distribution

  • Reduces visceral fat accumulation

  • Helps relieve sleep disruption and hot flashes that interfere with metabolism

Even more powerful, research shows women using MHT plus semaglutide lost 30 percent more weight than those using semaglutide alone. Read more here: GLP-1 and Menopausal Hormone Therapy: A Powerful Combination

Yes, GLP 1s and MHT can safely be used together.


🌿 Why This Matters in Midlife

Hormonal shifts lower estrogen, which affects:

  • Insulin sensitivity

  • Fat distribution

  • Muscle mass

  • Inflammation

That is why weight gain in midlife is not just about calories in and calories out. A comprehensive metabolic approach is often necessary.

At Alloy, we take a holistic approach that includes:

  • Physician guided metabolic screening

  • Hormone therapy when appropriate

  • GLP 1 medications if you qualify

  • Ongoing monitoring and support

If you are ready to see if you qualify for medical weight care, you can start here: Start Medical Weight Care

You deserve solutions that match what your body is actually going through in midlife.


This answer was created using the following resources: